Aim of the virtual conference is to facilitate Indian Pharma Industry adopt Green & Sustainable Chemistry as a tool to enhance Economic & Environmental Competitiveness
The product is expected to be available in a week’s time
Prucalopride medicine in the form of Orally Disintegrating Strips are most convenient dosage form for geriatric patients
FDA changes inspection classification of the facility to Voluntary Action Indicated
The total cost of the project is estimated at Rs 30 crore
The company will provide recyclability services to brands with a final goal to help them move to fully recyclable packaging
The facility will supply clinical trial materials for the development of vaccines and biologics up to Phase II stage and is expected to be fully operational by early 2023.
The company has also started working with a large pharma company on the API supply of a recently launched animal and human health product
The Indian medical devices industry has been in focus since the pandemic. From US $ 11 billion in 2020 it is expected to touch US $ 50 billion by 2025. Mehernosh Daruwalla, Founder and MD, Lotus Surgicals shares a perspective with Thomas C Thottathil on the opportunities in this sector
Betting big on talent, resources, and the ecosystem required for innovation and enterprise, Prime Minister Narendra Modi invited stakeholders to ideate in India, innovate in India and Make in India for the world
Subscribe To Our Newsletter & Stay Updated
